Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
33
BCLI Quote, Financials, Valuation and Earnings
Last price:
$1.18
Seasonality move
:
53.36%
Day range:
$1.18 - $1.23
52-week range:
$0.72 - $6.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
219.5K
Avg. volume:
433.2K
1-year change:
-80.2%
Market cap:
$9.5M
Revenue:
--
EPS (TTM):
-$2.07
Brainstorm Cell Therapeutics SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
BCLI
Brainstorm Cell Therapeutics
|
05/14/2024 | 10-Q | 10-Q filing on 05/14/2024 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
11/14/2023 | 10-Q | 10-Q filing on 11/14/2023 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
08/14/2023 | 10-Q | 10-Q filing on 08/14/2023 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
05/15/2023 | 10-Q | 10-Q filing on 05/15/2023 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
11/14/2022 | 10-Q | 10-Q filing on 11/14/2022 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
08/15/2022 | 10-Q | 10-Q filing on 08/15/2022 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
05/16/2022 | 10-Q | 10-Q filing on 05/16/2022 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
11/15/2021 | 10-Q | 10-Q filing on 11/15/2021 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
08/05/2021 | 10-Q | 10-Q filing on 08/05/2021 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
04/26/2021 | 10-Q | 10-Q filing on 04/26/2021 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
02/04/2021 | 10-K | 10-K filing on 02/04/2021 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
10/15/2020 | 10-Q | 10-Q filing on 10/15/2020 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
08/05/2020 | 10-Q | 10-Q filing on 08/05/2020 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
05/07/2020 | 10-Q | 10-Q filing on 05/07/2020 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
02/18/2020 | 10-K | 10-K filing on 02/18/2020 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
11/14/2019 | 10-Q | 10-Q filing on 11/14/2019 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
08/13/2019 | 10-Q | 10-Q filing on 08/13/2019 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
05/10/2019 | 10-Q | 10-Q filing on 05/10/2019 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
04/01/2019 | 10-K | 10-K filing on 04/01/2019 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
03/29/2019 | 10-K | 10-K filing on 03/29/2019 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
10/29/2018 | 10-Q | 10-Q filing on 10/29/2018 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
07/23/2018 | 10-Q | 10-Q filing on 07/23/2018 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
05/14/2018 | 10-Q | 10-Q filing on 05/14/2018 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
03/08/2018 | 10-K | 10-K filing on 03/08/2018 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
10/17/2017 | 10-Q | 10-Q filing on 10/17/2017 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
08/14/2017 | 10-Q | 10-Q filing on 08/14/2017 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
05/15/2017 | 10-Q | 10-Q filing on 05/15/2017 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
03/29/2017 | 10-K | 10-K filing on 03/29/2017 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
11/14/2016 | 10-Q | 10-Q filing on 11/14/2016 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
08/11/2016 | 10-Q | 10-Q filing on 08/11/2016 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
05/10/2016 | 10-Q | 10-Q filing on 05/10/2016 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
03/09/2016 | 10-K | 10-K filing on 03/09/2016 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
11/16/2015 | 10-Q | 10-Q filing on 11/16/2015 | View Form |
|
BCLI
Brainstorm Cell Therapeutics
|
08/13/2015 | 10-Q | 10-Q filing on 08/13/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
